
Our B2B Products
Our B2B Products
Our B2B Products
Our products
ViaDerma's product pipeline is built on the clinical strength of the patented SkinPass™ technology
ViaDerma's product pipeline is built on the clinical strength of the patented SkinPass™ technology
SkinPass™ technology fuels our entire family of topical solutions. Because this delivery platform is both patented and versatile, we have engineered a vast portfolio of specialized medicines designed to bypass the epidermal barrier and deliver institutional-grade healing directly to the source of infection or inflammation.
SkinPass™ technology fuels our entire family of topical solutions. Because this delivery platform is both patented and versatile, we have engineered a vast portfolio of specialized medicines designed to bypass the epidermal barrier and deliver institutional-grade healing directly to the source of infection or inflammation.
buy vitastem
VitaStem®
Topical Antibiotic.
Our flagship product.
buy vitastem
VitaStem® Topical Antibiotic. Our flagship product.
Deep Dermal Delivery: Penetrates outer skin barriers to eliminate bacteria deep within the tissue, not just on the surface.
Broad-Spectrum Efficacy: Clinically shown to kill >99.0% of bacteria in 60 seconds, including MRSA, MSSA, and P. aeruginosa.
FDA-Listed Formula: Doctor-formulated for rapid healing across acute wounds, burns, and chronic diabetic ulcers.


Instructions for Use
Four-Step Instruction.
Four-Step Instruction.
Three times daily.
01
Apply directly
Apply as droplets directly to the wound bed. Use enough to cover the affected tissue.
02
Massage in lightly
With clean, gloved hands, lightly massage the solution into the tissue.
03
Cover if needed
Cover with dressing for protected sites. Leave open for hot spots and superficial lesions.
04
Three times daily
Repeat application three times daily until full healing.
Powered by SkinPass™
Patented Faster Absorption
and Penetration
Deeper, faster delivery for topical medications — throughout the entire lesion.
01 Penetrates Skin Barrier
02 Targets Entire Infection
03 Creates Protective Barrier
Powered by SkinPass™
Patented Faster Absorption
and Penetration
Deeper, faster delivery for topical medications — throughout the entire lesion.
01 Penetrates Skin Barrier
02 Targets Entire Infection
03 Creates Protective Barrier
Intellectual Property
A Protected Global Patent
Our technology is anchored by a robust and expanding intellectual property portfolio.
U.S. Patent No. 12,465,567: Awarded in 2025, this covers our "Enhanced Antibiotic and Drug Delivery" for both human and veterinary applications.
Strategic Exclusivity: Our portfolio includes 20 additional Continuation-in-Part (CIP) patent applications, establishing Via Pellé’s dominance in the transdermal delivery landscape.
Our technology is anchored by a robust and expanding intellectual property portfolio.
U.S. Patent No. 12,465,567: Awarded in 2025, this covers our "Enhanced Antibiotic and Drug Delivery" for both human and veterinary applications.
Strategic Exclusivity: Our portfolio includes 20 additional Continuation-in-Part (CIP) patent applications, establishing Via Pellé’s dominance in the transdermal delivery landscape.

Learn more on a call with a specialist
Schedule a free consultation with our sales team representative and discover how Via Pellé can bring innovation into your medical facility

Learn more on a call with a specialist
Schedule a free consultation with our sales team representative and discover how Via Pellé can bring innovation into your medical facility

Learn more on a call with a specialist
Schedule a free consultation with our sales team representative and discover how Via Pellé can bring innovation into your medical facility